Interim monitoring report on statutory-funded residential rehabilitation placements
Placements approved by Alcohol and Drug Partnerships between 1 April 2021 to 30 September 2022
A Management Information Statistics publication for Scotland
- Published
- 20 December 2022
- Type
- Statistical report
- Author
- Public Health Scotland
About this release
This is the fifth report on Residential Rehabilitation within the Monitoring and Evaluation Programme led by Public Health Scotland. The report presents information on the number of Alcohol and Drug Partnership (ADP) statutory funded placements into residential rehabilitation, with estimated costs, that were approved between 1 April 2021 and 30 September 2022. Information is provided at a Scotland level, NHS Board and each Alcohol and Drug Partnership.
Main points
- In Q2 2022/23, 181 statutory funded placements were approved for residential rehabilitation in Scotland. This is an increase of 67 placements when compared to Q2 2021/22 (n=114), and an increase of 11 placements when compared to Q1 2022/23 (n=170).
- Of the 181 placements approved in Q2 2022/23, 155 placements were approved by ADPs; 15 placements were approved by Ward 5 Woodland View in NHS Ayrshire and Arran, and 11 placements were approved on the new Prison to Rehab pathway. Figure 1 below shows the total number of ADP approved placements, and the yearly average, from 1 April 2021 to 30 September 2022.
- The total estimated cost for 181 placements was £1,716,071. This cost is made up of £1,341,310 from 155 ADP approved placements, £225,180 for 15 placements in Ward 5 Woodland View, and £149,581 for 11 Prison to Rehab placements.
- The highest number of ADP approved placements (n=63) since April 2021, occurred in August 2022.
- Information on the characteristics of individuals offered placements was available for the ADP approved placements (n=155), in Q2 2022/23, and this showed:
- 64% of placements were for males (n=99), and 36% of placements were for females (n=56).
- 59% (n=91) of the 155 ADP approved placements were for people with problematic alcohol use, 25% (n=39) was for people with problematic drug use, and 16% (n=25), was for people with co-dependency.
- The largest number of approved placements by Alcohol and Drug Partnerships was in Glasgow City (n=39,25%), followed MELDAP (Midlothian and East Lothian ADP) (n=15, 10%) then Highland (n=14,9%). Please note that the figure for Highland includes nine placements for a two-week treatment programme, and five placements for a 14-week treatment programme. Caution must be made when comparing data between ADPs.
- MELDAP reported the highest estimated total cost for placements (£147,586), followed by Dumfries and Galloway ADP (£139,595), then Glasgow City (£130,500).
- The most common reason for ADPs submitting a nil return during Q2 2022/23 was a lack of referrals for residential rehabilitation.
- Overall, between 1 April 2021 and 30 September 2022, 891 statutory funded placements (includes ADP, P2R and Ward 5 data) for residential rehabilitation were approved in Scotland. The total estimated cost was £6,659,289.
Background
Residential rehabilitation is a well-established intervention for the treatment of drug and alcohol problems and is recognised as an important option for some people requiring treatment. As part of the National Mission, the Scottish Government has committed to invest £100M for residential rehabilitation over the next five years. Since 2021/22, and for the next five years, the Alcohol and Drugs Partnerships in Scotland have been allocated £13.5M, with £5M earmarked to support additional capacity and access Residential Rehabilitation services.
Further information
The next release of this publication will be 21 March 2023.
General enquiries
If you have an enquiry relating to this publication, please email phs.evaluationteam@phs.scot.
Media enquiries
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.
Requesting other formats and reporting issues
If you require publications or documents in other formats, please email phs.otherformats@phs.scot.
To report any issues with a publication, please email phs.generalpublications@phs.scot.
Older versions of this publication
Versions of this publication released before 16 March 2020 may be found on the Data and Intelligence, Health Protection Scotland or Improving Health websites.